[
  {
    "title": "A股异动丨华东医药涨逾5% ELAHERE获美FDA加速批准上市 系卵巢癌治疗领域巨大突破",
    "href": "http://stock.jrj.com.cn/2022/11/16103937142691.shtml",
    "datetime": "2022-11-16 10:39:25",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：ELAHERE获美FDA加速批准上市 系卵巢癌治疗领域的巨大突破！",
    "href": "http://stock.jrj.com.cn/2022/11/15182437141078.shtml",
    "datetime": "2022-11-15 18:24:18",
    "code": "000963"
  },
  {
    "title": "华东医药控股股东远大集团质押1985万股 用于续贷质押",
    "href": "http://stock.jrj.com.cn/2022/11/11205237132754.shtml",
    "datetime": "2022-11-11 20:52:52",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药涨逾5% 连续两季度营收及净利润保持双位数增长",
    "href": "http://stock.jrj.com.cn/2022/10/26142737085304.shtml",
    "datetime": "2022-10-26 14:27:30",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：第三季度净利6.41亿元，同比增长7.71%",
    "href": "http://stock.jrj.com.cn/2022/10/25230437083755.shtml",
    "datetime": "2022-10-25 23:04:15",
    "code": "000963"
  },
  {
    "title": "华东医药2022年前三季度净利19.81亿同比增长4.54% 本期出售不动产",
    "href": "http://stock.jrj.com.cn/2022/10/25215037083515.shtml",
    "datetime": "2022-10-25 21:50:58",
    "code": "000963"
  },
  {
    "title": "华东医药涨停 Q3扣非净利润预增7%-15%",
    "href": "http://stock.jrj.com.cn/2022/10/13101037052006.shtml",
    "datetime": "2022-10-13 10:10:29",
    "code": "000963"
  },
  {
    "title": "华东医药2022年前三季度预计净利19.71亿-20.66亿同比增长4%-9% 各业务板块良好增长",
    "href": "http://stock.jrj.com.cn/2022/10/12211137051245.shtml",
    "datetime": "2022-10-12 21:11:21",
    "code": "000963"
  },
  {
    "title": "华东医药：预计今年前三季度盈利19.71亿至20.66亿元",
    "href": "http://stock.jrj.com.cn/2022/10/12194437051029.shtml",
    "datetime": "2022-10-12 19:44:07",
    "code": "000963"
  },
  {
    "title": "华东医药：前三季度净利同比预增4%-9%",
    "href": "http://stock.jrj.com.cn/2022/10/12192237050923.shtml",
    "datetime": "2022-10-12 19:22:50",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)第三季度净利润预增6%-11%",
    "href": "http://stock.jrj.com.cn/2022/10/12191237050917.shtml",
    "datetime": "2022-10-12 19:12:50",
    "code": "000963"
  },
  {
    "title": "华东医药回应股价波动：公司医美机构占营收比重很小",
    "href": "http://stock.jrj.com.cn/2022/09/19123037004252.shtml",
    "datetime": "2022-09-19 12:30:26",
    "code": "000963"
  },
  {
    "title": "华东医药“少女针”热销但贡献较小 新增长点还看创新药管线",
    "href": "http://stock.jrj.com.cn/2022/08/25074436933748.shtml",
    "datetime": "2022-08-25 07:44:50",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：德国联邦金融监管局批准通过Heidelberg Pharma的公开增发方案",
    "href": "http://stock.jrj.com.cn/2022/08/15184436901323.shtml",
    "datetime": "2022-08-15 18:44:21",
    "code": "000963"
  },
  {
    "title": "华东医药2022年上半年业绩出炉：产品推广及服务费16.8亿元 长期借款增加11.6亿元",
    "href": "http://stock.jrj.com.cn/2022/08/10171136887105.shtml",
    "datetime": "2022-08-10 17:11:01",
    "code": "000963"
  },
  {
    "title": "华东医药披露2022年半年报，实现净利润13.41亿元",
    "href": "http://stock.jrj.com.cn/2022/08/10143636886418.shtml",
    "datetime": "2022-08-10 14:36:11",
    "code": "000963"
  },
  {
    "title": "2022年上半年营利双增，华东医药获头部公私募积极加仓",
    "href": "http://stock.jrj.com.cn/2022/08/10100136885602.shtml",
    "datetime": "2022-08-10 10:01:04",
    "code": "000963"
  },
  {
    "title": "华东医药2022年上半年净利13.41亿同比增长3.09% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2022/08/09223136884673.shtml",
    "datetime": "2022-08-09 22:31:34",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：中美华东拟以增资和受让股份方式获华仁科技60%股权",
    "href": "http://stock.jrj.com.cn/2022/08/09201536884225.shtml",
    "datetime": "2022-08-09 20:15:48",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/08/09201336884228.shtml",
    "datetime": "2022-08-09 20:13:27",
    "code": "000963"
  },
  {
    "title": "华东医药：拟以不超3.96亿元收购华仁科技60%股权",
    "href": "http://stock.jrj.com.cn/2022/08/09200436884151.shtml",
    "datetime": "2022-08-09 20:04:59",
    "code": "000963"
  },
  {
    "title": "华东医药：上半年实现净利润13.4亿元 同比增长3.09%",
    "href": "http://stock.jrj.com.cn/2022/08/09195736884126.shtml",
    "datetime": "2022-08-09 19:57:40",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)半年度净利润13.41亿元、同比增长3.09%",
    "href": "http://stock.jrj.com.cn/2022/08/09194736884097.shtml",
    "datetime": "2022-08-09 19:47:34",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：肾小球滤过率动态监测系统医疗器械注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/07/18170836821612.shtml",
    "datetime": "2022-07-18 17:08:48",
    "code": "000963"
  },
  {
    "title": "华东医药：两家子公司三款药品拟中标第七批全国药品集采",
    "href": "http://stock.jrj.com.cn/2022/07/13142236807070.shtml",
    "datetime": "2022-07-13 14:22:22",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：3款药品拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/13121836806812.shtml",
    "datetime": "2022-07-13 12:18:43",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：司美格鲁肽注射液获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/06/30172736771916.shtml",
    "datetime": "2022-06-30 17:27:48",
    "code": "000963"
  },
  {
    "title": "下一个风口！PE不足20倍的医美王者，细分赛道布局全面领先爱美客、华东医药",
    "href": "http://stock.jrj.com.cn/hotstock/2022/06/14182636728478.shtml",
    "datetime": "2022-06-14 18:26:10",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)2021年度权益分派10派2.9元 股权登记日为6月10日",
    "href": "http://stock.jrj.com.cn/2022/06/07143636708807.shtml",
    "datetime": "2022-06-07 14:36:08",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：控股股东质押及解质2700万股",
    "href": "http://stock.jrj.com.cn/2022/05/20160336665755.shtml",
    "datetime": "2022-05-20 16:03:40",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：拟增加经营范围“易制毒化学品(二类、三类)”",
    "href": "http://stock.jrj.com.cn/2022/05/11184236635475.shtml",
    "datetime": "2022-05-11 18:42:15",
    "code": "000963"
  },
  {
    "title": "华东医药2022年第一季度净利7.04亿同比减少7.12% 其他收益同比减少",
    "href": "http://stock.jrj.com.cn/2022/05/04171136557651.shtml",
    "datetime": "2022-05-04 17:11:43",
    "code": "000963"
  },
  {
    "title": "华东医药2021年净利23.02亿同比下滑18.38% 董事长吕梁薪酬240万",
    "href": "http://stock.jrj.com.cn/2022/04/28095236490784.shtml",
    "datetime": "2022-04-28 09:52:57",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：一季度净利降7.12%至7.04亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27234236487778.shtml",
    "datetime": "2022-04-27 23:42:50",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)2021年度净利降18.38%至23.02亿元 拟10派2.9元",
    "href": "http://stock.jrj.com.cn/2022/04/27234036487779.shtml",
    "datetime": "2022-04-27 23:40:31",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：道尔生物注射用DR10624获新西兰Medsafe及HDEC临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/04/07173236268484.shtml",
    "datetime": "2022-04-07 17:32:14",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司合作研发项目美国临床试验进展 已达到主要研究终点",
    "href": "http://stock.jrj.com.cn/2022/03/21095134854316.shtml",
    "datetime": "2022-03-21 09:51:43",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：合作方ImmunoGen预计Mirvetuximab本月在美递交BLA",
    "href": "http://stock.jrj.com.cn/2022/03/21092734854152.shtml",
    "datetime": "2022-03-21 09:27:31",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：控股子公司华东宁波不再纳入合并范围",
    "href": "http://stock.jrj.com.cn/2022/03/15181034830112.shtml",
    "datetime": "2022-03-15 18:10:46",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司与Kiniksa签署产品独家许可协议 加快推进创新国际化进程",
    "href": "http://stock.jrj.com.cn/2022/02/23114134442671.shtml",
    "datetime": "2022-02-23 11:41:52",
    "code": "000963"
  },
  {
    "title": "华东医药子公司获得美国上市公司Kiniksa两款产品独家许可 涉及费用6.62亿美元",
    "href": "http://stock.jrj.com.cn/2022/02/23103034441922.shtml",
    "datetime": "2022-02-23 10:30:02",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药(000963.SZ)涨4% 获两款自身免疫产品独家许可权",
    "href": "http://stock.jrj.com.cn/2022/02/23095134441804.shtml",
    "datetime": "2022-02-23 09:51:51",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：中美华东引进Kiniksa两款自身免疫领域全球创新产品",
    "href": "http://stock.jrj.com.cn/2022/02/23083834441485.shtml",
    "datetime": "2022-02-23 08:38:07",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：注射用DR30303获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/01/19182734174984.shtml",
    "datetime": "2022-01-19 18:27:45",
    "code": "000963"
  },
  {
    "title": "171家公司被机构调研 华东医药最受关注",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/13082134152578.shtml",
    "datetime": "2022-01-13 08:21:35",
    "code": "000963"
  },
  {
    "title": "基金、券商以及外资集体调研华东医药，附属收购华昌高科拟打造核苷生产基地",
    "href": "http://stock.jrj.com.cn/2022/01/10174934141962.shtml",
    "datetime": "2022-01-10 17:49:45",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药创逾5个月新高 子公司中美华东拟收购破产重整后的华昌高科100%股权",
    "href": "http://stock.jrj.com.cn/2021/12/29111234080289.shtml",
    "datetime": "2021-12-29 11:12:26",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：子公司中美华东拟收购破产重整后的华昌高科100%股权",
    "href": "http://stock.jrj.com.cn/2021/12/28193834077565.shtml",
    "datetime": "2021-12-28 19:38:06",
    "code": "000963"
  },
  {
    "title": "为了“美”这档事，华东医药“母子内斗”再起波澜",
    "href": "http://stock.jrj.com.cn/2021/12/17084334025658.shtml",
    "datetime": "2021-12-17 08:43:10",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：中美华东二甲双胍恩格列净片(Ⅰ)新纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03175433960806.shtml",
    "datetime": "2021-12-03 17:54:11",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：1类新药IMGN853美国关键性单臂临床试验达到主要研究终点",
    "href": "http://stock.jrj.com.cn/2021/12/01081433947961.shtml",
    "datetime": "2021-12-01 08:14:24",
    "code": "000963"
  },
  {
    "title": "华东医药注射用达托霉素获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2021/11/29103233936443.shtml",
    "datetime": "2021-11-29 10:32:06",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司药品注射用达托霉素获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2021/11/28195233930049.shtml",
    "datetime": "2021-11-28 19:52:44",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)全资子公司药品注射用达托霉素获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2021/11/28170933929720.shtml",
    "datetime": "2021-11-28 17:09:15",
    "code": "000963"
  },
  {
    "title": "华东医药全资子公司拟投资1亿成立湖北美琪健康科技有限公司 持股40%",
    "href": "http://stock.jrj.com.cn/2021/11/11213533837933.shtml",
    "datetime": "2021-11-11 21:35:53",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：肾小球滤过率动态监测系统进入创新医疗器械特别审查程序",
    "href": "http://stock.jrj.com.cn/2021/11/09163833827895.shtml",
    "datetime": "2021-11-09 16:38:23",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：第三季度净利降9.88%至5.95亿元",
    "href": "http://stock.jrj.com.cn/2021/10/26205533757084.shtml",
    "datetime": "2021-10-26 20:55:43",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药10月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/10/08180333658508.shtml",
    "datetime": "2021-10-08 18:03:04",
    "code": "000963"
  },
  {
    "title": "可持续发展ETF（515090）涨2.22%！华东医药封板涨停，保险行业领涨",
    "href": "http://stock.jrj.com.cn/2021/10/08144833657300.shtml",
    "datetime": "2021-10-08 14:48:57",
    "code": "000963"
  },
  {
    "title": "华东医药涨停！与武田签署独家协议，引进糖尿病创新产品",
    "href": "http://stock.jrj.com.cn/2021/10/08101433656161.shtml",
    "datetime": "2021-10-08 10:14:21",
    "code": "000963"
  },
  {
    "title": "华东医药英国子公司获得比利时KiOmed四款在研创新型壳聚糖医美产品的独家许可",
    "href": "http://stock.jrj.com.cn/2021/10/08100433656114.shtml",
    "datetime": "2021-10-08 10:04:42",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药(000963.SZ)涨9% 子公司英国Sinclair与KiOmed签署独家许可协议",
    "href": "http://stock.jrj.com.cn/2021/10/08095133656010.shtml",
    "datetime": "2021-10-08 09:51:00",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：子公司英国Sinclair与KiOmed签署独家许可协议 引入创新型壳聚糖医美产品",
    "href": "http://stock.jrj.com.cn/2021/10/08091333655765.shtml",
    "datetime": "2021-10-08 09:13:48",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司英国Sinclair签署医美产品独家许可协议",
    "href": "http://stock.jrj.com.cn/2021/10/07190933646834.shtml",
    "datetime": "2021-10-07 19:09:56",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：奥硝唑片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/29192133537824.shtml",
    "datetime": "2021-09-29 19:21:10",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司药品注册上市许可申请获受理】",
    "href": "http://stock.jrj.com.cn/2021/09/05170533385900.shtml",
    "datetime": "2021-09-05 17:05:39",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：利拉鲁肽注射液“适用于成人2型糖尿病患者控制血糖”上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2021/09/05163833385838.shtml",
    "datetime": "2021-09-05 16:38:49",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药8月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/08/26180333325440.shtml",
    "datetime": "2021-08-26 18:03:41",
    "code": "000963"
  },
  {
    "title": "华东医药跌4.98% 中信证券高点喊买目标价60元",
    "href": "http://stock.jrj.com.cn/2021/08/25165333317003.shtml",
    "datetime": "2021-08-25 16:53:00",
    "code": "000963"
  },
  {
    "title": "华东医药供应链管理公司浙江遭整改 GSP飞检4项缺陷",
    "href": "http://stock.jrj.com.cn/2021/08/17162033267054.shtml",
    "datetime": "2021-08-17 16:20:00",
    "code": "000963"
  },
  {
    "title": "因核心子公司毛利下降 华东医药上半年净利降逾24%",
    "href": "http://stock.jrj.com.cn/2021/08/10163633232692.shtml",
    "datetime": "2021-08-10 16:36:06",
    "code": "000963"
  },
  {
    "title": "华东医药2021年上半年净利13亿 较上年同期下滑24.89%",
    "href": "http://stock.jrj.com.cn/2021/08/09220133227568.shtml",
    "datetime": "2021-08-09 22:01:37",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)半年度净利润降24.89%至13亿元",
    "href": "http://stock.jrj.com.cn/2021/08/09195733226929.shtml",
    "datetime": "2021-08-09 19:57:05",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2021/08/01172033180789.shtml",
    "datetime": "2021-08-01 17:20:04",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)全资子公司获得药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2021/08/01161633180664.shtml",
    "datetime": "2021-08-01 16:16:39",
    "code": "000963"
  },
  {
    "title": "华东医药控股股东远大集团质押970万股 用于续贷质押",
    "href": "http://stock.jrj.com.cn/2021/07/20213433126055.shtml",
    "datetime": "2021-07-20 21:34:47",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：控股股东质押970万股",
    "href": "http://stock.jrj.com.cn/2021/07/20181433125191.shtml",
    "datetime": "2021-07-20 18:14:48",
    "code": "000963"
  },
  {
    "title": "华东医药控股股东远大集团质押830万股 用于续贷质押",
    "href": "http://stock.jrj.com.cn/2021/07/07210133060343.shtml",
    "datetime": "2021-07-07 21:01:39",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：注射用地西他滨(祥珂)拟中标第五批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23201832984852.shtml",
    "datetime": "2021-06-23 20:18:25",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：中美华东奥美拉唑碳酸氢钠胶囊获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/22181232977238.shtml",
    "datetime": "2021-06-22 18:12:26",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：中美华东注射用米卡芬净钠获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/18164532955036.shtml",
    "datetime": "2021-06-18 16:45:17",
    "code": "000963"
  },
  {
    "title": "华东医药：未来公司将继续坚定不移的推动科研创新和国际化发展战略",
    "href": "http://stock.jrj.com.cn/2021/06/09153232899722.shtml",
    "datetime": "2021-06-09 15:32:26",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：二甲双胍恩格列净片(I)获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/07192332888322.shtml",
    "datetime": "2021-06-07 19:23:18",
    "code": "000963"
  },
  {
    "title": "华东医药：由瑞士Kylane设计和开发的高级透明质酸填充物MaiLi系列 和同类产品相比维持效果更好",
    "href": "http://stock.jrj.com.cn/2021/06/01211332859387.shtml",
    "datetime": "2021-06-01 21:13:46",
    "code": "000963"
  },
  {
    "title": "华东医药：公司医药商业所具备的盈利能力和管理水平已有实力成为同类商业公司中的优秀企业",
    "href": "http://stock.jrj.com.cn/2021/06/01183532858336.shtml",
    "datetime": "2021-06-01 18:35:53",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)2020年度权益分派10派2.3元 股权登记日为6月8日",
    "href": "http://stock.jrj.com.cn/2021/06/01180032858032.shtml",
    "datetime": "2021-06-01 18:00:35",
    "code": "000963"
  },
  {
    "title": "华东医药：公司已按计划开展Ellansé伊妍仕产品的营销团队建设、品牌和市场传播等相关的上市推广准备工作",
    "href": "http://stock.jrj.com.cn/2021/06/01174832857972.shtml",
    "datetime": "2021-06-01 17:48:25",
    "code": "000963"
  },
  {
    "title": "华东医药：公司吡格列酮二甲双胍（卡双平）和吲哚布芬2020年销售收入同比均实现翻倍增长",
    "href": "http://stock.jrj.com.cn/2021/06/01170832857545.shtml",
    "datetime": "2021-06-01 17:08:33",
    "code": "000963"
  },
  {
    "title": "华东医药：海外生产基地目前的布局适合当前的业务发展情况 目前生产均保持稳定",
    "href": "http://stock.jrj.com.cn/2021/06/01170832857539.shtml",
    "datetime": "2021-06-01 17:08:28",
    "code": "000963"
  },
  {
    "title": "华东医药：公司百令胶囊正在按制定的销售计划推进相关工作目前销量保持稳定增长状态",
    "href": "http://stock.jrj.com.cn/2021/06/01170732857531.shtml",
    "datetime": "2021-06-01 17:07:37",
    "code": "000963"
  },
  {
    "title": "华东医药：中国远大集团有限责任公司为公司第一大股东 为自然人控股公司",
    "href": "http://stock.jrj.com.cn/2021/06/01162932857126.shtml",
    "datetime": "2021-06-01 16:29:17",
    "code": "000963"
  },
  {
    "title": "华东医药：公司正在就符合政策鼓励的医美产品制定在海南注册工作计划",
    "href": "http://stock.jrj.com.cn/2021/06/01162432857080.shtml",
    "datetime": "2021-06-01 16:24:38",
    "code": "000963"
  },
  {
    "title": "华东医药：公司固定资产折旧采用年限平均法",
    "href": "http://stock.jrj.com.cn/2021/06/01162132857056.shtml",
    "datetime": "2021-06-01 16:21:59",
    "code": "000963"
  },
  {
    "title": "华东医药：公司业务覆盖医药全产业链 以医药工业为主导 同时拓展医药商业和医美产业",
    "href": "http://stock.jrj.com.cn/2021/06/01162032857055.shtml",
    "datetime": "2021-06-01 16:20:52",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：生物制品1类新药IMGN853另一中国关键性单臂临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/05/27221432832265.shtml",
    "datetime": "2021-05-27 22:14:17",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：HDM3001产品(QX001S)将于6月开展Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/25174332817177.shtml",
    "datetime": "2021-05-25 17:43:40",
    "code": "000963"
  },
  {
    "title": "浙江震元(000705.SZ)：拟将不超200万股的华东医药股份 用于参与转融通证券出借交易",
    "href": "http://stock.jrj.com.cn/2021/05/21165332793889.shtml",
    "datetime": "2021-05-21 16:53:11",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：控股股东解除质押1952万股",
    "href": "http://stock.jrj.com.cn/2021/05/20195232788867.shtml",
    "datetime": "2021-05-20 19:52:07",
    "code": "000963"
  },
  {
    "title": "华东医药(000963)：控股股东部分股份解除质押",
    "href": "http://stock.jrj.com.cn/2021/05/20194332789804.shtml",
    "datetime": "2021-05-20 19:43:12",
    "code": "000963"
  },
  {
    "title": "华东医药：含利多卡因Perfectha产品获欧盟CE认证 正积极筹备Glacial Spa?中国上市销售工作",
    "href": "http://stock.jrj.com.cn/2021/05/17202432771123.shtml",
    "datetime": "2021-05-17 20:24:09",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：1类新药MB102注射液(Relmapirazin)国际多中心Ⅲ期临试申请获批",
    "href": "http://stock.jrj.com.cn/2021/05/12170632742649.shtml",
    "datetime": "2021-05-12 17:06:34",
    "code": "000963"
  },
  {
    "title": "浙江震元：公司目前持有华东医药286.56万股 最初投资成本为52.8万元",
    "href": "http://stock.jrj.com.cn/2021/05/07172232711852.shtml",
    "datetime": "2021-05-07 17:22:25",
    "code": "000963"
  },
  {
    "title": "华东医药2日挫17%，爱美客挫16%！医美超级泡沫破裂了吗？",
    "href": "http://stock.jrj.com.cn/2021/05/07151632707945.shtml",
    "datetime": "2021-05-07 15:16:13",
    "code": "000963"
  },
  {
    "title": "华东医药(000963)：拟于5月11日下午举行网上业绩说明会",
    "href": "http://stock.jrj.com.cn/2021/05/06200132703280.shtml",
    "datetime": "2021-05-06 20:01:20",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药5月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/06180532702470.shtml",
    "datetime": "2021-05-06 18:05:33",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药4月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/30180332488223.shtml",
    "datetime": "2021-04-30 18:03:32",
    "code": "000963"
  },
  {
    "title": "港A医美概念股集体爆发！华东医药、贝泰妮、瑞丽医美等多股创历史新高",
    "href": "http://stock.jrj.com.cn/2021/04/30114932485951.shtml",
    "datetime": "2021-04-30 11:49:55",
    "code": "000963"
  },
  {
    "title": "A股异动丨华东医药(000963.SZ)涨停续创新高 市值超900亿元",
    "href": "http://stock.jrj.com.cn/2021/04/30101332485203.shtml",
    "datetime": "2021-04-30 10:13:55",
    "code": "000963"
  },
  {
    "title": "华东医药：2020年公司医药工业研发总投入14.44亿元 同比增长8.91%",
    "href": "http://stock.jrj.com.cn/2021/04/29205332482306.shtml",
    "datetime": "2021-04-29 20:53:49",
    "code": "000963"
  },
  {
    "title": "华东医药：目前主要化学原料药均已通过美国 FDA 认证",
    "href": "http://stock.jrj.com.cn/2021/04/29194932481904.shtml",
    "datetime": "2021-04-29 19:49:10",
    "code": "000963"
  },
  {
    "title": "华东医药：医美医院目前不是公司医美业务的发展重点",
    "href": "http://stock.jrj.com.cn/2021/04/29192632481759.shtml",
    "datetime": "2021-04-29 19:26:42",
    "code": "000963"
  },
  {
    "title": "华东医药：公司2020年持续加强研发创新工作完成创新项目立项15项",
    "href": "http://stock.jrj.com.cn/2021/04/29190632481473.shtml",
    "datetime": "2021-04-29 19:06:48",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)一季度净利润降33.9%至7.58亿元",
    "href": "http://stock.jrj.com.cn/2021/04/27172132463813.shtml",
    "datetime": "2021-04-27 17:21:44",
    "code": "000963"
  },
  {
    "title": "医美板块走强 华东医药再创新高",
    "href": "http://stock.jrj.com.cn/2021/04/26095832452083.shtml",
    "datetime": "2021-04-26 09:58:41",
    "code": "000963"
  },
  {
    "title": "东吴证券：持续全面看多医美 重点推荐爱美客、华东医药等",
    "href": "http://stock.jrj.com.cn/2021/04/26073032450848.shtml",
    "datetime": "2021-04-26 07:30:05",
    "code": "000963"
  },
  {
    "title": "华东医药2020年营收下降，股价却创新高 市场更看好其医美业务？",
    "href": "http://stock.jrj.com.cn/2021/04/21195932418335.shtml",
    "datetime": "2021-04-21 19:59:18",
    "code": "000963"
  },
  {
    "title": "数据复盘：医药生物、银行等4个行业获主力资金青睐 机构抢筹华东医药等股",
    "href": "http://stock.jrj.com.cn/2021/04/21191832417957.shtml",
    "datetime": "2021-04-21 19:18:48",
    "code": "000963"
  },
  {
    "title": "华东医药去年营收降净利原地走 国际医美营收降37%",
    "href": "http://stock.jrj.com.cn/2021/04/21153832416278.shtml",
    "datetime": "2021-04-21 15:38:00",
    "code": "000963"
  },
  {
    "title": "华东医药2020年净利增长0.24% 董事长吕梁薪酬240万",
    "href": "http://stock.jrj.com.cn/2021/04/21153432416240.shtml",
    "datetime": "2021-04-21 15:34:52",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：拟投资建设生命科学产业园项目一期和二期",
    "href": "http://stock.jrj.com.cn/2021/04/21151432416119.shtml",
    "datetime": "2021-04-21 15:14:00",
    "code": "000963"
  },
  {
    "title": "医美股强势回归 华东医药(000963.SZ)创历史新高",
    "href": "http://stock.jrj.com.cn/2021/04/21114132415266.shtml",
    "datetime": "2021-04-21 11:41:49",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)2020年度净利润升0.24%至28.2亿元 拟10派2.3元",
    "href": "http://stock.jrj.com.cn/2021/04/20205732411974.shtml",
    "datetime": "2021-04-20 20:57:10",
    "code": "000963"
  },
  {
    "title": "华东医药宣布入股诺灵生物 打造ADC产业链闭环",
    "href": "http://stock.jrj.com.cn/2021/04/19192532403629.shtml",
    "datetime": "2021-04-19 19:25:27",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)盘中创历史新高 年内累涨近60%",
    "href": "http://stock.jrj.com.cn/2021/04/16103632384917.shtml",
    "datetime": "2021-04-16 10:36:09",
    "code": "000963"
  },
  {
    "title": "瞄准身体塑形赛道！华东医药6.6亿元完成西班牙医美公司收购",
    "href": "http://stock.jrj.com.cn/2021/04/15165132380167.shtml",
    "datetime": "2021-04-15 16:51:25",
    "code": "000963"
  },
  {
    "title": "一剂“少女针” 医美又嗨了！华东医药涨停，金发拉比翻倍",
    "href": "http://stock.jrj.com.cn/2021/04/15072332376593.shtml",
    "datetime": "2021-04-15 07:23:49",
    "code": "000963"
  },
  {
    "title": "“少女针”获批 入局8年，华东医药在医美领域战果如何？",
    "href": "http://stock.jrj.com.cn/2021/04/14190932373132.shtml",
    "datetime": "2021-04-14 19:09:28",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药4月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/14180232372759.shtml",
    "datetime": "2021-04-14 18:02:22",
    "code": "000963"
  },
  {
    "title": "一剂“少女针”，医美又嗨了！华东医药涨停，金发拉比翻倍",
    "href": "http://stock.jrj.com.cn/2021/04/14175532372694.shtml",
    "datetime": "2021-04-14 17:55:00",
    "code": "000963"
  },
  {
    "title": "“少女针”获批，华东医药涨停，封单近20万手",
    "href": "http://stock.jrj.com.cn/2021/04/14131932370956.shtml",
    "datetime": "2021-04-14 13:19:59",
    "code": "000963"
  },
  {
    "title": "华东医药早盘放量涨停 医美板块提振大涨",
    "href": "http://stock.jrj.com.cn/2021/04/14100832369727.shtml",
    "datetime": "2021-04-14 10:08:51",
    "code": "000963"
  },
  {
    "title": "A股异动丨华东医药(000963.SZ)逼近涨停 医美产品获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/04/14094332369489.shtml",
    "datetime": "2021-04-14 09:43:41",
    "code": "000963"
  },
  {
    "title": "又一重磅医美产品！华东医药“少女针”获批 概念股要high？",
    "href": "http://stock.jrj.com.cn/2021/04/13215032367188.shtml",
    "datetime": "2021-04-13 21:50:28",
    "code": "000963"
  },
  {
    "title": "华东医药：注射用聚己内酯微球面部填充剂获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/04/13194132366565.shtml",
    "datetime": "2021-04-13 19:41:02",
    "code": "000963"
  },
  {
    "title": "华东医药：公司本产业基金主要投向医美内分泌器官移植抗排异消化道肿瘤肾科免疫等领域的初创早期项目",
    "href": "http://stock.jrj.com.cn/2021/04/12151632357740.shtml",
    "datetime": "2021-04-12 15:16:07",
    "code": "000963"
  },
  {
    "title": "华东医药：公司目前没有您所说的分拆少女针的相关计划",
    "href": "http://stock.jrj.com.cn/2021/04/12151532357741.shtml",
    "datetime": "2021-04-12 15:15:17",
    "code": "000963"
  },
  {
    "title": "华东医药：公司新型胶原蛋白刺激剂Ellansé目前尚未在美国上市",
    "href": "http://stock.jrj.com.cn/2021/04/12151332357705.shtml",
    "datetime": "2021-04-12 15:13:03",
    "code": "000963"
  },
  {
    "title": "华东医药：公司治疗晚期非小细胞肺癌的迈华替尼正在进行同步开展二期及三期临床试验",
    "href": "http://stock.jrj.com.cn/2021/04/12151232357704.shtml",
    "datetime": "2021-04-12 15:12:25",
    "code": "000963"
  },
  {
    "title": "华东医药：公司全资子公司中美华东已收到国家药品监督管理局（NMPA）核准签发的《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2021/04/12151232357707.shtml",
    "datetime": "2021-04-12 15:12:21",
    "code": "000963"
  },
  {
    "title": "华东医药：百令胶囊OTC品种属于药品",
    "href": "http://stock.jrj.com.cn/2021/04/12151132357706.shtml",
    "datetime": "2021-04-12 15:11:36",
    "code": "000963"
  },
  {
    "title": "华东医药：公司英国全资子公司新型胶原蛋白刺激剂Ellansé正在等待中国上市的注册审批",
    "href": "http://stock.jrj.com.cn/2021/04/12151132357710.shtml",
    "datetime": "2021-04-12 15:11:30",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：医药产业基金已完成基金备案",
    "href": "http://stock.jrj.com.cn/2021/04/06174432319908.shtml",
    "datetime": "2021-04-06 17:44:32",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：生物制品1类新药IMGN853临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2021/03/31171932256854.shtml",
    "datetime": "2021-03-31 17:19:37",
    "code": "000963"
  },
  {
    "title": "华东医药：公司已基本完成有关中国境内、境外投资主管部门和有关投资监管机构的项目申报和备案工作",
    "href": "http://stock.jrj.com.cn/2021/03/31154632256077.shtml",
    "datetime": "2021-03-31 15:46:47",
    "code": "000963"
  },
  {
    "title": "华东医药：赛缪斯SANTEMUSE是一个为基于肤质基因检测的个性化护肤解决方案",
    "href": "http://stock.jrj.com.cn/2021/03/31154632256035.shtml",
    "datetime": "2021-03-31 15:46:25",
    "code": "000963"
  },
  {
    "title": "华东医药：“悦可医疗美容诊所”目前未有在全国布局的规划",
    "href": "http://stock.jrj.com.cn/2021/03/31154532256033.shtml",
    "datetime": "2021-03-31 15:45:48",
    "code": "000963"
  },
  {
    "title": "华东医药：公司已提交了新型胶原蛋白刺激剂Ellansé在中国的注册申请并获受理",
    "href": "http://stock.jrj.com.cn/2021/03/31154432256034.shtml",
    "datetime": "2021-03-31 15:44:49",
    "code": "000963"
  },
  {
    "title": "华东医药：公司百令胶囊处方药品种的新包装已上市",
    "href": "http://stock.jrj.com.cn/2021/03/31154432256032.shtml",
    "datetime": "2021-03-31 15:44:35",
    "code": "000963"
  },
  {
    "title": "华东医药：公司恩格列净二甲双胍复方片（5/500mg）已申报生产",
    "href": "http://stock.jrj.com.cn/2021/03/31154332256019.shtml",
    "datetime": "2021-03-31 15:43:47",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司新型胶原蛋白刺激剂Ellansé正在等待中国上市的注册审批",
    "href": "http://stock.jrj.com.cn/2021/03/31154232256018.shtml",
    "datetime": "2021-03-31 15:42:23",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药3月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/24180332209721.shtml",
    "datetime": "2021-03-24 18:03:01",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药3月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/23180232202748.shtml",
    "datetime": "2021-03-23 18:02:23",
    "code": "000963"
  },
  {
    "title": "华东医药：公司目前未有达格列净二甲双胍产品",
    "href": "http://stock.jrj.com.cn/2021/03/19160232164253.shtml",
    "datetime": "2021-03-19 16:02:01",
    "code": "000963"
  },
  {
    "title": "强势突破机构大买华东医药 游资恐高急忙兑现南网能源",
    "href": "http://stock.jrj.com.cn/2021/03/19082832161490.shtml",
    "datetime": "2021-03-19 08:28:48",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药3月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/18180432158365.shtml",
    "datetime": "2021-03-18 18:04:05",
    "code": "000963"
  },
  {
    "title": "医美板块再度活跃 华东医药大涨超8%",
    "href": "http://stock.jrj.com.cn/2021/03/18100832155693.shtml",
    "datetime": "2021-03-18 10:08:50",
    "code": "000963"
  },
  {
    "title": "华东医药：公司阿卡波糖咀嚼片参与了本次国家医保局的医保续约谈判并谈判成功",
    "href": "http://stock.jrj.com.cn/2021/03/11162032109672.shtml",
    "datetime": "2021-03-11 16:20:36",
    "code": "000963"
  },
  {
    "title": "华东医药：公司江东二期项目目前尚未正式投产目前产能利用率未受影响",
    "href": "http://stock.jrj.com.cn/2021/03/11161432109673.shtml",
    "datetime": "2021-03-11 16:14:21",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：1类新药MB-102注射液(Relmapirazin)临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/03/08193832092599.shtml",
    "datetime": "2021-03-08 19:38:53",
    "code": "000963"
  },
  {
    "title": "华东医药砸20亿对外并购 英国子公司能否扛起“医美”大旗",
    "href": "http://stock.jrj.com.cn/2021/03/08073432088992.shtml",
    "datetime": "2021-03-08 07:34:47",
    "code": "000963"
  },
  {
    "title": "转型慢半拍的华东医药，“医美+创新药”这波收购操作为何深受市场认可？",
    "href": "http://stock.jrj.com.cn/2021/03/07075132083221.shtml",
    "datetime": "2021-03-07 07:51:10",
    "code": "000963"
  },
  {
    "title": "冷冻溶脂核心产品获欧盟CE认证 华东医药盘中创新高",
    "href": "http://stock.jrj.com.cn/2021/03/04150932070830.shtml",
    "datetime": "2021-03-04 15:09:26",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药3月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/01180432051441.shtml",
    "datetime": "2021-03-01 18:04:04",
    "code": "000963"
  },
  {
    "title": "华东医药：目前尚未正式规划江东三期项目",
    "href": "http://stock.jrj.com.cn/2021/02/25155332025661.shtml",
    "datetime": "2021-02-25 15:53:21",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药2月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/23180232013386.shtml",
    "datetime": "2021-02-23 18:02:32",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)封涨停板 月内累涨超40%",
    "href": "http://stock.jrj.com.cn/2021/02/23131532011842.shtml",
    "datetime": "2021-02-23 13:15:47",
    "code": "000963"
  },
  {
    "title": "A股异动丨华东医药(000963.SZ)续升近7%创阶段新高 5日累计飙涨40%",
    "href": "http://stock.jrj.com.cn/2021/02/22095132004007.shtml",
    "datetime": "2021-02-22 09:51:23",
    "code": "000963"
  },
  {
    "title": "华东医药18.8亿加码医美+创新药，业绩低迷谋转型新赛道主营仅占0.76%",
    "href": "http://stock.jrj.com.cn/2021/02/19104531991384.shtml",
    "datetime": "2021-02-19 10:45:10",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药2月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/18180431987650.shtml",
    "datetime": "2021-02-18 18:04:11",
    "code": "000963"
  },
  {
    "title": "3日飚30%！华东医药转型之路现曙光？",
    "href": "http://stock.jrj.com.cn/2021/02/18174231987445.shtml",
    "datetime": "2021-02-18 17:42:01",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：获得双特异性抗体PRV-3279两个临床适应症于大中华区独家临床开发及商业权",
    "href": "http://stock.jrj.com.cn/2021/02/18142831985860.shtml",
    "datetime": "2021-02-18 14:28:33",
    "code": "000963"
  },
  {
    "title": "华东医药拓展全球化运营，拟投资不超8500欧元收购西班牙医美公司",
    "href": "http://stock.jrj.com.cn/2021/02/18115731985330.shtml",
    "datetime": "2021-02-18 11:57:55",
    "code": "000963"
  },
  {
    "title": "A股异动丨华东医药(000963.SZ)逼近涨停 再购海外医美公司",
    "href": "http://stock.jrj.com.cn/2021/02/18094431984489.shtml",
    "datetime": "2021-02-18 09:44:11",
    "code": "000963"
  },
  {
    "title": "早间公告：开山股份拟美国收购地热项目",
    "href": "http://stock.jrj.com.cn/2021/02/18081831984160.shtml",
    "datetime": "2021-02-18 08:18:51",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：拟收购西班牙能量源型医美器械公司High Tech 100%股权",
    "href": "http://stock.jrj.com.cn/2021/02/17165931974349.shtml",
    "datetime": "2021-02-17 16:59:05",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：控股股东质押8000万股及解押9914.4万股",
    "href": "http://stock.jrj.com.cn/2021/02/17161931974217.shtml",
    "datetime": "2021-02-17 16:19:26",
    "code": "000963"
  },
  {
    "title": "华东医药全资子公司参加第四批全国药品集中采购投标工作",
    "href": "http://stock.jrj.com.cn/2021/02/03212831845020.shtml",
    "datetime": "2021-02-03 21:28:55",
    "code": "000963"
  },
  {
    "title": "华东医药：公司泮托拉唑注射剂拟中标第四批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/02/03180831844219.shtml",
    "datetime": "2021-02-03 18:08:17",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：生物制品1类新药IMGN853临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/01/20192131730687.shtml",
    "datetime": "2021-01-20 19:21:20",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖片的院外销售比例也呈现逐步增长态势目前已超过院内销售",
    "href": "http://stock.jrj.com.cn/2021/01/08171131656080.shtml",
    "datetime": "2021-01-08 17:11:18",
    "code": "000963"
  },
  {
    "title": "华东医药：公司立足于医药健康产业 以医药工业为主导 同时拓展医药商业和医美产业",
    "href": "http://stock.jrj.com.cn/2021/01/08165931656001.shtml",
    "datetime": "2021-01-08 16:59:56",
    "code": "000963"
  },
  {
    "title": "华东医药：为了进一步夯实循证证据百令胶囊已计划启动全国大型多中心临床研究",
    "href": "http://stock.jrj.com.cn/2021/01/08163731655606.shtml",
    "datetime": "2021-01-08 16:37:49",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)拟斥9800万元参投医药产业基金",
    "href": "http://stock.jrj.com.cn/2021/01/07172731648772.shtml",
    "datetime": "2021-01-07 17:27:52",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：百令胶囊和阿卡波糖咀嚼片医保谈判成功",
    "href": "http://stock.jrj.com.cn/2020/12/29183231596590.shtml",
    "datetime": "2020-12-29 18:32:30",
    "code": "000963"
  },
  {
    "title": "华东医药：公司阿卡波糖咀嚼片目前已在全国市场正常销售",
    "href": "http://stock.jrj.com.cn/2020/12/25161931570562.shtml",
    "datetime": "2020-12-25 16:19:49",
    "code": "000963"
  },
  {
    "title": "华东医药：目前尚未正式规划江东三期项目",
    "href": "http://stock.jrj.com.cn/2020/12/25161731570548.shtml",
    "datetime": "2020-12-25 16:17:38",
    "code": "000963"
  },
  {
    "title": "华东医药：公司百令胶囊及移植免疫产品今年均保持稳定增长",
    "href": "http://stock.jrj.com.cn/2020/12/17145231509266.shtml",
    "datetime": "2020-12-17 14:52:40",
    "code": "000963"
  },
  {
    "title": "华东医药：公司今后仍将继续重点覆盖自费及零售OTC市场",
    "href": "http://stock.jrj.com.cn/2020/12/08155431440112.shtml",
    "datetime": "2020-12-08 15:54:17",
    "code": "000963"
  },
  {
    "title": "华东医药：公司江东二期项目从2017年7月开工建设目前已基本建成",
    "href": "http://stock.jrj.com.cn/2020/12/08154431440049.shtml",
    "datetime": "2020-12-08 15:44:23",
    "code": "000963"
  },
  {
    "title": "华东医药：预计公司阿那曲唑片及多潘立酮片销量将迎来较快增长",
    "href": "http://stock.jrj.com.cn/2020/12/08153431439937.shtml",
    "datetime": "2020-12-08 15:34:47",
    "code": "000963"
  },
  {
    "title": "华东医药：公司业务覆盖全国超2400余家三甲医院，占全部三甲医院比重超90%",
    "href": "http://stock.jrj.com.cn/2020/12/08151131439771.shtml",
    "datetime": "2020-12-08 15:11:23",
    "code": "000963"
  },
  {
    "title": "华东医药：公司在美国波士顿和硅谷设立联合科研办事处 目前开展的工作以创新项目BD为主",
    "href": "http://stock.jrj.com.cn/2020/12/08150831439758.shtml",
    "datetime": "2020-12-08 15:08:50",
    "code": "000963"
  },
  {
    "title": "华东医药：目前公司阿那曲唑片及多潘立酮片的各中标省市都已陆续开始执行",
    "href": "http://stock.jrj.com.cn/2020/12/08150631439737.shtml",
    "datetime": "2020-12-08 15:06:25",
    "code": "000963"
  },
  {
    "title": "华东医药：公司英国全资子公司Sinclair在全球拥有荷兰、法国达迪利、美国密歇根和瑞士四大生产基地",
    "href": "http://stock.jrj.com.cn/2020/12/08150531439736.shtml",
    "datetime": "2020-12-08 15:05:43",
    "code": "000963"
  },
  {
    "title": "华东医药：RCEP的签署对公司创新转型国际化战略实施将产生积极影响",
    "href": "http://stock.jrj.com.cn/2020/11/25105231344477.shtml",
    "datetime": "2020-11-25 10:52:55",
    "code": "000963"
  },
  {
    "title": "[太安堂]加强合作:华东医药商务部销售总监谢永新一行拜访康爱多",
    "href": "http://stock.jrj.com.cn/2020/11/18000031306633.shtml",
    "datetime": "2020-11-18 00:00:00",
    "code": "000963"
  },
  {
    "title": "华东医药：位于伦敦的Sinclair公司是公司全资子公司和医美业务全球化运营平台",
    "href": "http://stock.jrj.com.cn/2020/11/09131831240302.shtml",
    "datetime": "2020-11-09 13:18:10",
    "code": "000963"
  },
  {
    "title": "华东医药：公司糖尿病领域恩格列净二甲双胍复方片（5/500mg）已申报生产 已有产能规划",
    "href": "http://stock.jrj.com.cn/2020/11/09131731240300.shtml",
    "datetime": "2020-11-09 13:17:08",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药11月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/11/05180231222609.shtml",
    "datetime": "2020-11-05 18:02:10",
    "code": "000963"
  },
  {
    "title": "连续第二日大涨 华东医药(000963.SZ)股价创2年新高",
    "href": "http://stock.jrj.com.cn/2020/11/05101631219625.shtml",
    "datetime": "2020-11-05 10:16:12",
    "code": "000963"
  },
  {
    "title": "【龙虎榜】华东医药11月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/11/04180031215605.shtml",
    "datetime": "2020-11-04 18:00:55",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药(000963.SZ)放量大涨8% 绩后获多家券商唱好",
    "href": "http://stock.jrj.com.cn/2020/11/04101531213636.shtml",
    "datetime": "2020-11-04 10:15:00",
    "code": "000963"
  },
  {
    "title": "华东医药：公司医药制造、医药商业、医美业务三大板块今年三季度均保持良好发展态势",
    "href": "http://stock.jrj.com.cn/2020/10/30094831173600.shtml",
    "datetime": "2020-10-30 09:48:44",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司英国Sinclair第三季度营业收入较二季度已明显回升",
    "href": "http://stock.jrj.com.cn/2020/10/30094831173603.shtml",
    "datetime": "2020-10-30 09:48:29",
    "code": "000963"
  },
  {
    "title": "华东医药打造可持续发展新动能：创新转型与国际化 | 聚焦国内医药生物产业重要公司",
    "href": "http://stock.jrj.com.cn/2020/10/29115531156679.shtml",
    "datetime": "2020-10-29 11:55:48",
    "code": "000963"
  },
  {
    "title": "华东医药2020年前三季度净利23.91亿增长8.06% 融资成本降低",
    "href": "http://stock.jrj.com.cn/2020/10/27092431139853.shtml",
    "datetime": "2020-10-27 09:24:08",
    "code": "000963"
  },
  {
    "title": "华东医药欲扩张医美版图 公司医美业务负责人：当前产品以引进为主",
    "href": "http://stock.jrj.com.cn/2020/10/23192931118149.shtml",
    "datetime": "2020-10-23 19:29:45",
    "code": "000963"
  },
  {
    "title": "我国新冠疫苗年产能预计年底将达6.1亿剂 华东医药与ImmunoGen达成战略合作布局ADC抗肿瘤领域 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/10/20183931093580.shtml",
    "datetime": "2020-10-20 18:39:08",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司与ImmunoGen签署产品独家临床开发及商业化协议",
    "href": "http://stock.jrj.com.cn/2020/10/20103931090445.shtml",
    "datetime": "2020-10-20 10:39:09",
    "code": "000963"
  },
  {
    "title": "A股异动 | 华东医药(000963.SZ)涨4.43% 与美国药企签署卵巢癌药品独家临床开发和商业化协议",
    "href": "http://stock.jrj.com.cn/2020/10/20101331090276.shtml",
    "datetime": "2020-10-20 10:13:28",
    "code": "000963"
  },
  {
    "title": "华东医药(000963.SZ)：与ImmunoGen签署抗卵巢癌药独家临床开发和商业化协议",
    "href": "http://stock.jrj.com.cn/2020/10/20083531089755.shtml",
    "datetime": "2020-10-20 08:35:18",
    "code": "000963"
  },
  {
    "title": "华东医药加码医美产业布局 收购瑞士玻尿酸企业20%股权",
    "href": "http://stock.jrj.com.cn/2020/10/16020231063455.shtml",
    "datetime": "2020-10-16 02:02:47",
    "code": "000963"
  },
  {
    "title": "华东医药全资子公司出资600万欧元受让Kylane公司20%股权",
    "href": "http://stock.jrj.com.cn/2020/10/15213431062433.shtml",
    "datetime": "2020-10-15 21:34:18",
    "code": "000963"
  },
  {
    "title": "华东医药加注心血管领域 年销1200万的腺苷注射液会有多大市场？",
    "href": "http://stock.jrj.com.cn/2020/09/17193330771271.shtml",
    "datetime": "2020-09-17 19:33:05",
    "code": "000963"
  },
  {
    "title": "华东医药：公司计划将在今年内启动A型肉毒素产品在中国境内的注册报批工作",
    "href": "http://stock.jrj.com.cn/2020/09/17162730770105.shtml",
    "datetime": "2020-09-17 16:27:32",
    "code": "000963"
  },
  {
    "title": "华东医药：本次交易与Sinclair获得Kylane公司MaiLi系列产品的全球经销权项目无关联",
    "href": "http://stock.jrj.com.cn/2020/09/17162630770107.shtml",
    "datetime": "2020-09-17 16:26:35",
    "code": "000963"
  },
  {
    "title": "华东医药：抗肿瘤类药物阿那曲唑片已于今年8月获生产批文",
    "href": "http://stock.jrj.com.cn/2020/09/17162230770089.shtml",
    "datetime": "2020-09-17 16:22:41",
    "code": "000963"
  },
  {
    "title": "华东医药：今年一季度公司英国全资子公司Sinclair与瑞士医美研究机构Kylane公司合作",
    "href": "http://stock.jrj.com.cn/2020/09/17162230770087.shtml",
    "datetime": "2020-09-17 16:22:38",
    "code": "000963"
  },
  {
    "title": "华东医药：目前总代理韩国伊婉玻尿酸产品2018年销售规模超6亿元 2019年保持稳定发展并有小幅增长",
    "href": "http://stock.jrj.com.cn/2020/09/17162230770090.shtml",
    "datetime": "2020-09-17 16:22:34",
    "code": "000963"
  },
  {
    "title": "华东医药：消化道产品线（包括主要产品泮托拉唑胶囊和冻干粉针两种剂型）总体增长约25%",
    "href": "http://stock.jrj.com.cn/2020/09/17161830770047.shtml",
    "datetime": "2020-09-17 16:18:23",
    "code": "000963"
  },
  {
    "title": "重要品种憾失集采后 华东医药海外市场获新突破",
    "href": "http://stock.jrj.com.cn/2020/09/01030730647218.shtml",
    "datetime": "2020-09-01 03:07:09",
    "code": "000963"
  },
  {
    "title": "华东医药主力产品阿卡波糖片获得美国FDA批文",
    "href": "http://stock.jrj.com.cn/2020/08/31180230644536.shtml",
    "datetime": "2020-08-31 18:02:15",
    "code": "000963"
  },
  {
    "title": "华东医药2020年上半年净利17.31亿 同比增长8.45%",
    "href": "http://stock.jrj.com.cn/2020/08/28184330615712.shtml",
    "datetime": "2020-08-28 18:43:25",
    "code": "000963"
  },
  {
    "title": "华东医药发布半年报：医药工业逆势增长 多个创新产品临近收获期",
    "href": "http://stock.jrj.com.cn/2020/08/28121430612943.shtml",
    "datetime": "2020-08-28 12:14:11",
    "code": "000963"
  },
  {
    "title": "华东医药：上半年实现归母净利润17.31亿元 同比增长8.45%",
    "href": "http://stock.jrj.com.cn/2020/08/28091630611514.shtml",
    "datetime": "2020-08-28 09:16:00",
    "code": "000963"
  },
  {
    "title": "华东医药上半年医药工业板块实现营收利润逆势双增长",
    "href": "http://stock.jrj.com.cn/2020/08/28090130611443.shtml",
    "datetime": "2020-08-28 09:01:06",
    "code": "000963"
  },
  {
    "title": "华东医药上半年净利润17.31亿元 同比增长8.45%",
    "href": "http://stock.jrj.com.cn/2020/08/27230430607483.shtml",
    "datetime": "2020-08-27 23:04:08",
    "code": "000963"
  },
  {
    "title": "第三批全国药品集中采购大会召开 华东医药阿那曲唑片、多潘立酮片双双中标",
    "href": "http://stock.jrj.com.cn/2020/08/20153230549365.shtml",
    "datetime": "2020-08-20 15:32:00",
    "code": "000963"
  },
  {
    "title": "华东医药阿那曲唑片、多潘立酮片双双中标第三批国采",
    "href": "http://stock.jrj.com.cn/2020/08/20152630549295.shtml",
    "datetime": "2020-08-20 15:26:00",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖咀嚼片已在全国正常销售 销量在逐月提升中",
    "href": "http://stock.jrj.com.cn/2020/08/13124030490847.shtml",
    "datetime": "2020-08-13 12:40:22",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司拥有开展疫苗配送业务的资质 具有专业较完备的冷链物流配送体系",
    "href": "http://stock.jrj.com.cn/2020/08/04172130424722.shtml",
    "datetime": "2020-08-04 17:21:28",
    "code": "000963"
  },
  {
    "title": "华东医药携两大品种“轻装上阵”参与集采",
    "href": "http://stock.jrj.com.cn/2020/08/03220830415684.shtml",
    "datetime": "2020-08-03 22:08:43",
    "code": "000963"
  },
  {
    "title": "华东医药：糖尿病类西格列汀二甲双胍片已通过审评 年底前有望获得生产批文",
    "href": "http://stock.jrj.com.cn/2020/07/07144130166858.shtml",
    "datetime": "2020-07-07 14:41:15",
    "code": "000963"
  },
  {
    "title": "华东医药：多潘立酮片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/06/08223129874591.shtml",
    "datetime": "2020-06-08 22:31:27",
    "code": "000963"
  },
  {
    "title": "华东医药股东远大集团质押866万股 用于续贷质押",
    "href": "http://stock.jrj.com.cn/2020/05/25214829762418.shtml",
    "datetime": "2020-05-25 21:48:49",
    "code": "000963"
  },
  {
    "title": "核心产品“丢标”后华东医药如何转型？ 董秘陈波：重视创新项目，坚决淘汰低壁垒仿制药",
    "href": "http://stock.jrj.com.cn/2020/05/20212029724179.shtml",
    "datetime": "2020-05-20 21:20:12",
    "code": "000963"
  },
  {
    "title": "华东医药增加经营范围 提供中药代煎服务",
    "href": "http://stock.jrj.com.cn/2020/05/13210829663667.shtml",
    "datetime": "2020-05-13 21:08:52",
    "code": "000963"
  },
  {
    "title": "华东医药2020年一季度净利11.47亿增长26.46% 存款利息增加",
    "href": "http://stock.jrj.com.cn/2020/05/01182129440751.shtml",
    "datetime": "2020-05-01 18:21:54",
    "code": "000963"
  },
  {
    "title": "华东医药2019年净利28.13亿增长24.08% 四大产品线均保持良好增长趋势",
    "href": "http://stock.jrj.com.cn/2020/04/29143729418829.shtml",
    "datetime": "2020-04-29 14:37:21",
    "code": "000963"
  },
  {
    "title": "华东医药2019年营收净利双增 医药工业板块营收首破百亿",
    "href": "http://stock.jrj.com.cn/2020/04/28105429402606.shtml",
    "datetime": "2020-04-28 10:54:45",
    "code": "000963"
  },
  {
    "title": "持续加大研发投入 华东医药全面转型创新药企",
    "href": "http://stock.jrj.com.cn/2020/04/28093229401425.shtml",
    "datetime": "2020-04-28 09:32:31",
    "code": "000963"
  },
  {
    "title": "华东医药：2019年营收净利双增长 转型创新药企",
    "href": "http://stock.jrj.com.cn/2020/04/28092329401431.shtml",
    "datetime": "2020-04-28 09:23:00",
    "code": "000963"
  },
  {
    "title": "华东医药：2019年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2020/04/28035029399330.shtml",
    "datetime": "2020-04-28 03:50:00",
    "code": "000963"
  },
  {
    "title": "华东医药股东远大集团质押314万股 用于续贷质押",
    "href": "http://stock.jrj.com.cn/2020/03/25210129108747.shtml",
    "datetime": "2020-03-25 21:01:30",
    "code": "000963"
  },
  {
    "title": "华东医药：公司及全资子公司杭州中美华东制药已于2月10日正式复工",
    "href": "http://stock.jrj.com.cn/2020/02/10222728805087.shtml",
    "datetime": "2020-02-10 22:27:00",
    "code": "000963"
  },
  {
    "title": "华东医药：主要产品百令胶囊被纳入浙江省疾控系统防控用品类别清单",
    "href": "http://stock.jrj.com.cn/2020/02/03191228757509.shtml",
    "datetime": "2020-02-03 19:12:32",
    "code": "000963"
  },
  {
    "title": "华东医药：已累计捐赠价值600多万元百令胶囊药品",
    "href": "http://stock.jrj.com.cn/2020/02/03164828756587.shtml",
    "datetime": "2020-02-03 16:48:27",
    "code": "000963"
  },
  {
    "title": "华东医药：公司主要产品百令胶囊被纳入浙江省疾控系统防控用品类别清单",
    "href": "http://stock.jrj.com.cn/2020/02/03162928756503.shtml",
    "datetime": "2020-02-03 16:29:00",
    "code": "000963"
  },
  {
    "title": "华东医药：成立疫情应急处置小组 将确保关键药械的供应保障和价格稳定",
    "href": "http://stock.jrj.com.cn/2020/01/23110528726838.shtml",
    "datetime": "2020-01-23 11:05:00",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖仍有巨大发展空间 有信心争取保持全年业绩增长",
    "href": "http://stock.jrj.com.cn/2020/01/21100428711680.shtml",
    "datetime": "2020-01-21 10:04:00",
    "code": "000963"
  },
  {
    "title": "华东医药子公司中美华东未中标国家组织药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/20114428705129.shtml",
    "datetime": "2020-01-20 11:44:07",
    "code": "000963"
  },
  {
    "title": "华东医药：全资子公司阿卡波糖片未能中标第二批国家药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/20093428704111.shtml",
    "datetime": "2020-01-20 09:34:00",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖片未中标第二批国家组织药品集中采购的投标",
    "href": "http://stock.jrj.com.cn/2020/01/20085828703865.shtml",
    "datetime": "2020-01-20 08:58:00",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司核心品种阿卡波糖片未中标第二批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/20081128703708.shtml",
    "datetime": "2020-01-20 08:11:00",
    "code": "000963"
  },
  {
    "title": "华东医药：中美华东阿卡波糖片因价格因素未能中标",
    "href": "http://stock.jrj.com.cn/2020/01/20080628703684.shtml",
    "datetime": "2020-01-20 08:06:55",
    "code": "000963"
  },
  {
    "title": "快抛华东医药！国家带量采购现场惊人一幕，德国拜耳降价90%踢翻国内同行“金饭碗”...",
    "href": "http://stock.jrj.com.cn/2020/01/19175228701688.shtml",
    "datetime": "2020-01-19 17:52:57",
    "code": "000963"
  },
  {
    "title": "[解密]华东医药跌停只是行业洗牌开始？“带量采购”来势汹汹，仿制药企遇存亡危机",
    "href": "http://stock.jrj.com.cn/2020/01/19084328697222.shtml",
    "datetime": "2020-01-19 08:43:20",
    "code": "000963"
  },
  {
    "title": "阿卡波糖“集采落标” 华东医药：机构出货放量跌停",
    "href": "http://stock.jrj.com.cn/2020/01/18085728696115.shtml",
    "datetime": "2020-01-18 08:57:37",
    "code": "000963"
  },
  {
    "title": "20亿资金砸跌停 暴涨40倍的白马踩雷",
    "href": "http://stock.jrj.com.cn/2020/01/17194828694599.shtml",
    "datetime": "2020-01-17 19:48:12",
    "code": "000963"
  },
  {
    "title": "龙虎榜：华东医药放量跌停 两机构席位卖出1.48亿元",
    "href": "http://stock.jrj.com.cn/2020/01/17163228693199.shtml",
    "datetime": "2020-01-17 16:32:00",
    "code": "000963"
  },
  {
    "title": "华东医药午后跌停 成交额超8亿元",
    "href": "http://stock.jrj.com.cn/2020/01/17131028692099.shtml",
    "datetime": "2020-01-17 13:10:00",
    "code": "000963"
  },
  {
    "title": "华东医药大跌逾9%",
    "href": "http://stock.jrj.com.cn/2020/01/17120328691915.shtml",
    "datetime": "2020-01-17 12:03:00",
    "code": "000963"
  },
  {
    "title": "华东医药股价闪崩：第二轮药品集采阿卡波糖竞标 中美华东出局",
    "href": "http://stock.jrj.com.cn/2020/01/17114628691840.shtml",
    "datetime": "2020-01-17 11:46:05",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖片获得奥地利上市许可 主要用于降低血糖",
    "href": "http://stock.jrj.com.cn/2019/12/13174628530736.shtml",
    "datetime": "2019-12-13 17:46:25",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖片获奥地利上市许可",
    "href": "http://stock.jrj.com.cn/2019/12/13174128530722.shtml",
    "datetime": "2019-12-13 17:41:00",
    "code": "000963"
  },
  {
    "title": "华东医药：阿卡波糖片获得奥地利上市许可",
    "href": "http://stock.jrj.com.cn/2019/12/13174028530717.shtml",
    "datetime": "2019-12-13 17:40:39",
    "code": "000963"
  },
  {
    "title": "华东医药调整公司财务负责人",
    "href": "http://stock.jrj.com.cn/2019/11/29140828467992.shtml",
    "datetime": "2019-11-29 14:08:40",
    "code": "000963"
  },
  {
    "title": "华东医药第三季度盈利6.2亿 同比增长20%",
    "href": "http://stock.jrj.com.cn/2019/10/29215528320542.shtml",
    "datetime": "2019-10-29 21:55:03",
    "code": "000963"
  },
  {
    "title": "止步同业竞争 华东医药拟“执掌”佐力药业泡汤",
    "href": "http://stock.jrj.com.cn/2019/10/20210828272568.shtml",
    "datetime": "2019-10-20 21:08:00",
    "code": "000963"
  },
  {
    "title": "华东医药：终止意向收购佐力药业相应股权",
    "href": "http://stock.jrj.com.cn/2019/10/20173028272198.shtml",
    "datetime": "2019-10-20 17:30:00",
    "code": "000963"
  },
  {
    "title": "华东医药2020年开始力争每年至少上市一个创新药",
    "href": "http://stock.jrj.com.cn/2019/09/27162328191790.shtml",
    "datetime": "2019-09-27 16:23:47",
    "code": "000963"
  },
  {
    "title": "华东医药：2020年开始力争每年至少上市一个创新药",
    "href": "http://stock.jrj.com.cn/2019/09/27155228191673.shtml",
    "datetime": "2019-09-27 15:52:00",
    "code": "000963"
  },
  {
    "title": "华东医药：二季度研发投入最高 料全年研发费用将达10亿元",
    "href": "http://stock.jrj.com.cn/2019/08/30161128062933.shtml",
    "datetime": "2019-08-30 16:11:00",
    "code": "000963"
  },
  {
    "title": "医药股回调 机构净卖出华东医药、博雅生物",
    "href": "http://stock.jrj.com.cn/2019/08/28164228049612.shtml",
    "datetime": "2019-08-28 16:42:00",
    "code": "000963"
  },
  {
    "title": "复星医药龙头难保：同样取得15亿利润 华东医药销售费用仅为其60%",
    "href": "http://stock.jrj.com.cn/2019/08/28135528048957.shtml",
    "datetime": "2019-08-28 13:55:30",
    "code": "000963"
  },
  {
    "title": "华东医药2019年上半年盈利16亿 子公司业务增长",
    "href": "http://stock.jrj.com.cn/2019/08/27230928043615.shtml",
    "datetime": "2019-08-27 23:09:03",
    "code": "000963"
  },
  {
    "title": "华东医药上半年净利同比增长23%",
    "href": "http://stock.jrj.com.cn/2019/08/27200528042686.shtml",
    "datetime": "2019-08-27 20:05:23",
    "code": "000963"
  },
  {
    "title": "华东医药：两品种新纳入国家医保《药品目录》",
    "href": "http://stock.jrj.com.cn/2019/08/21163128010911.shtml",
    "datetime": "2019-08-21 16:31:00",
    "code": "000963"
  },
  {
    "title": "华东医药：相关产品新纳入2019版国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/21162928010883.shtml",
    "datetime": "2019-08-21 16:29:54",
    "code": "000963"
  },
  {
    "title": "华东医药：多个产品新纳入国家医保药品目录",
    "href": "http://stock.jrj.com.cn/2019/08/21162528010874.shtml",
    "datetime": "2019-08-21 16:25:06",
    "code": "000963"
  },
  {
    "title": "华东医药出资3000万美元 认购美国医疗光学诊断公司8.14%股份",
    "href": "http://stock.jrj.com.cn/2019/08/01122627915998.shtml",
    "datetime": "2019-08-01 12:26:09",
    "code": "000963"
  },
  {
    "title": "午间公告：华东医药拟3000万美元投资美企",
    "href": "http://stock.jrj.com.cn/2019/08/01120727914974.shtml",
    "datetime": "2019-08-01 12:07:29",
    "code": "000963"
  },
  {
    "title": "午间公告：华东医药与MediBeacon公司签署股权投资协议及产品商业化协议",
    "href": "http://stock.jrj.com.cn/2019/08/01115727915027.shtml",
    "datetime": "2019-08-01 11:57:00",
    "code": "000963"
  },
  {
    "title": "华东医药董事杨俊取得董事资格证书",
    "href": "http://stock.jrj.com.cn/2019/07/29203627900643.shtml",
    "datetime": "2019-07-29 20:36:46",
    "code": "000963"
  },
  {
    "title": "华东医药股东远大集团质押856万股 公司去年净利同比增长27%",
    "href": "http://stock.jrj.com.cn/2019/07/17085927850573.shtml",
    "datetime": "2019-07-17 08:59:28",
    "code": "000963"
  },
  {
    "title": "华东医药进入新老交替期 灵魂人物李邦良卸任董事长",
    "href": "http://stock.jrj.com.cn/2019/06/11025927683034.shtml",
    "datetime": "2019-06-11 02:59:46",
    "code": "000963"
  },
  {
    "title": "华东医药聘任李邦良为名誉董事长 2018年薪酬为220万元",
    "href": "http://stock.jrj.com.cn/2019/06/10190627681828.shtml",
    "datetime": "2019-06-10 19:06:18",
    "code": "000963"
  },
  {
    "title": "华东医药进入新老交替期 灵魂人物李邦良卸任董事长",
    "href": "http://stock.jrj.com.cn/2019/06/10155927681049.shtml",
    "datetime": "2019-06-10 15:59:00",
    "code": "000963"
  },
  {
    "title": "华东医药10亿收购案存疑 标的业绩连年下滑",
    "href": "http://stock.jrj.com.cn/2019/06/04050027660235.shtml",
    "datetime": "2019-06-04 05:00:27",
    "code": "000963"
  },
  {
    "title": "华东医药10.6亿慷慨收购或谋中药平台",
    "href": "http://stock.jrj.com.cn/2019/06/03080727656073.shtml",
    "datetime": "2019-06-03 08:07:52",
    "code": "000963"
  },
  {
    "title": "佐力药业易主 华东医药溢价收购遭质疑",
    "href": "http://stock.jrj.com.cn/2019/06/02081327653394.shtml",
    "datetime": "2019-06-02 08:13:55",
    "code": "000963"
  },
  {
    "title": "佐力药业易主 华东医药溢价收购遭质疑",
    "href": "http://stock.jrj.com.cn/2019/06/01102927651413.shtml",
    "datetime": "2019-06-01 10:29:38",
    "code": "000963"
  },
  {
    "title": "“A吃A”频现 业务整合成主因",
    "href": "http://stock.jrj.com.cn/2019/05/31014327643877.shtml",
    "datetime": "2019-05-31 01:43:21",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司TTP273片获得临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/05/29171127637943.shtml",
    "datetime": "2019-05-29 17:11:02",
    "code": "000963"
  },
  {
    "title": "华东医药：子公司收到TTP273片临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/05/29165927638439.shtml",
    "datetime": "2019-05-29 16:59:00",
    "code": "000963"
  },
  {
    "title": "华东医药拟花10亿并购 对方涨停自己大跌",
    "href": "http://stock.jrj.com.cn/2019/05/28021527628844.shtml",
    "datetime": "2019-05-28 02:15:44",
    "code": "000963"
  },
  {
    "title": "[振东制药]10.6亿元!华东医药收购药企——佐力药业",
    "href": "http://stock.jrj.com.cn/2019/05/28000027633441.shtml",
    "datetime": "2019-05-28 00:00:00",
    "code": "000963"
  },
  {
    "title": "[哈药股份]10.6亿元!华东医药收购佐力药业",
    "href": "http://stock.jrj.com.cn/2019/05/28000027633438.shtml",
    "datetime": "2019-05-28 00:00:00",
    "code": "000963"
  },
  {
    "title": "成全别人“陶冶”自己？花10亿并购 对方涨停自己大跌",
    "href": "http://stock.jrj.com.cn/2019/05/27213427628222.shtml",
    "datetime": "2019-05-27 21:34:41",
    "code": "000963"
  },
  {
    "title": "百亿医药白马联姻“绩差股”：华东医药一度跌停 佐力药业“搭便车”涨停？",
    "href": "http://stock.jrj.com.cn/2019/05/27125927626163.shtml",
    "datetime": "2019-05-27 12:59:15",
    "code": "000963"
  }
]